Acknowledgement to Referees.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1655, doi. 10.1007/s40262-023-01331-6
- Publication type:
- Article
Works matching IS 03125963 AND DT 2023 AND VI 62 AND IP 12
Results: 11
1
2
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1765, doi. 10.1007/s40262-023-01318-3
- By:
- Publication type:
- Article
3
A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1755, doi. 10.1007/s40262-023-01317-4
- By:
- Publication type:
- Article
4
Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1749, doi. 10.1007/s40262-023-01316-5
- By:
- Publication type:
- Article
5
Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, a Non-peptide GnRH Antagonist in Premenopausal Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1739, doi. 10.1007/s40262-023-01315-6
- By:
- Publication type:
- Article
6
Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs).
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1661, doi. 10.1007/s40262-023-01314-7
- By:
- Publication type:
- Article
7
Population Pharmacokinetics of Digoxin in Nonagenarian Patients: Optimization of the Dosing Regimen.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1725, doi. 10.1007/s40262-023-01313-8
- By:
- Publication type:
- Article
8
The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1673, doi. 10.1007/s40262-023-01312-9
- By:
- Publication type:
- Article
9
High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1695, doi. 10.1007/s40262-023-01311-w
- By:
- Publication type:
- Article
10
Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic Impairment.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1713, doi. 10.1007/s40262-023-01306-7
- By:
- Publication type:
- Article
11
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1701, doi. 10.1007/s40262-023-01305-8
- By:
- Publication type:
- Article